612 related articles for article (PubMed ID: 15727160)
1. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.
Schulz HU; Schürer M; Bässler D; Weiser D
Arzneimittelforschung; 2005; 55(1):15-22. PubMed ID: 15727160
[TBL] [Abstract][Full Text] [Related]
2. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.
Schulz HU; Schürer M; Bässler D; Weiser D
Arzneimittelforschung; 2005; 55(10):561-8. PubMed ID: 16294501
[TBL] [Abstract][Full Text] [Related]
3. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
Biber A; Fischer H; Römer A; Chatterjee SS
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():36-43. PubMed ID: 9684946
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers.
Staffeldt B; Kerb R; Brockmöller J; Ploch M; Roots I
J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S47-53. PubMed ID: 7857509
[TBL] [Abstract][Full Text] [Related]
5. Oral bioavailability of active principles from herbal products in humans. A study on Hypericum perforatum extracts using the soft gelatin capsule technology.
Agrosi M; Mischiatti S; Harrasser PC; Savio D
Phytomedicine; 2000 Dec; 7(6):455-62. PubMed ID: 11194173
[TBL] [Abstract][Full Text] [Related]
6. Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients.
Wurglics M; Schubert-Zsilavecz M
Clin Pharmacokinet; 2006; 45(5):449-68. PubMed ID: 16640452
[TBL] [Abstract][Full Text] [Related]
7. Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans.
Brockmöller J; Reum T; Bauer S; Kerb R; Hübner WD; Roots I
Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():94-101. PubMed ID: 9342768
[TBL] [Abstract][Full Text] [Related]
8. St. John's wort components and the brain: uptake, concentrations reached and the mechanisms underlying pharmacological effects.
Caccia S; Gobbi M
Curr Drug Metab; 2009 Nov; 10(9):1055-65. PubMed ID: 20214594
[TBL] [Abstract][Full Text] [Related]
9. Determination of hyperforin, hypericin, and pseudohypericin in human plasma using high-performance liquid chromatography analysis with fluorescence and ultraviolet detection.
Bauer S; Störmer E; Graubaum HJ; Roots I
J Chromatogr B Biomed Sci Appl; 2001 Dec; 765(1):29-35. PubMed ID: 11817306
[TBL] [Abstract][Full Text] [Related]
10. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models.
Butterweck V; Christoffel V; Nahrstedt A; Petereit F; Spengler B; Winterhoff H
Life Sci; 2003 Jun; 73(5):627-39. PubMed ID: 12770617
[TBL] [Abstract][Full Text] [Related]
11. Hypericin levels in human serum and interstitial skin blister fluid after oral single-dose and steady-state administration of Hypericum perforatum extract (St. John's wort).
Schempp CM; Winghofer B; Langheinrich M; Schöpf E; Simon JC
Skin Pharmacol Appl Skin Physiol; 1999; 12(5):299-304. PubMed ID: 10461100
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG.
Schellenberg R; Sauer S; Dimpfel W
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():44-53. PubMed ID: 9684947
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of total hypericin and hyperforin in St. John's wort extracts by HPLC with electrochemical detection.
Rückert U; Likussar W; Michelitsch A
Phytochem Anal; 2007; 18(3):204-8. PubMed ID: 17500362
[TBL] [Abstract][Full Text] [Related]
14. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
Laakmann G; Schüle C; Baghai T; Kieser M
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
[TBL] [Abstract][Full Text] [Related]
15. Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin.
Mueller SC; Uehleke B; Woehling H; Petzsch M; Majcher-Peszynska J; Hehl EM; Sievers H; Frank B; Riethling AK; Drewelow B
Clin Pharmacol Ther; 2004 Jun; 75(6):546-57. PubMed ID: 15179409
[TBL] [Abstract][Full Text] [Related]
16. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
Dimpfel W; Schober F; Mannel M
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
[TBL] [Abstract][Full Text] [Related]
17. Researching the antidepressant actions of Hypericum perforatum (St. John's wort) in animals and man.
Franklin M; Cowen PJ
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S29-37. PubMed ID: 11518072
[TBL] [Abstract][Full Text] [Related]
18. St. John's wort flavonoids and their metabolites show antidepressant activity and accumulate in brain after multiple oral doses.
Paulke A; Nöldner M; Schubert-Zsilavecz M; Wurglics M
Pharmazie; 2008 Apr; 63(4):296-302. PubMed ID: 18468390
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of the predominant hyperforins and hypericins in St. John's Wort (Hypericum perforatum L.) by liquid chromatography.
Gray DE; Rottinghaus GE; Garrett HE; Pallardy SG; Gray DE; Rottinghaus GE; Garrett HE; Pallardy SG
J AOAC Int; 2000; 83(4):944-9. PubMed ID: 10995119
[TBL] [Abstract][Full Text] [Related]
20. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
Vacek J; Klejdus B; Kubán V
Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
